Conference
OCOG-ALMERA: A phase II trial investigating the ability of metformin to chemo-radio-sensitize and prevent recurrence in locally advanced (LA) non-small cell lung cancer (NSCLC)∗
Authors
Tsakiridis T; Ellis P; Cutz J-C; Pond G; Wierzbicki M; Kavsak P; Wright J
Volume
11
Pagination
pp. s50-s51
Publisher
Elsevier
Publication Date
February 1, 2016
DOI
10.1016/j.jtho.2015.12.083
Conference proceedings
Journal of Thoracic Oncology
Issue
2
ISSN
1556-0864